Literature DB >> 2002342

Differences in the pharmacokinetics of cocaine in naive and cocaine-experienced rats.

H T Pan1, S Menacherry, J B Justice.   

Abstract

Enhanced cocaine concentrations in brain and blood observed after an intraperitoneal challenge dose in rats exposed to cocaine for 10 days by subcutaneous administration are traced to a change in the absorption process from the site of an intraperitoneal injection to general circulation. This conclusion is reached by three sets of corroborating results: (a) Adipose tissue of rats treated for 10 days with repeat subcutaneous injections of cocaine did not reveal a buildup of cocaine in sufficient concentrations to account for the twofold increase in brain and blood concentrations seen during intraperitoneal administration; (b) administration of the drug by an intravenous route after 10-day cocaine treatment did not show a significant difference between treatment and control groups; (c) nonlinear regression on the intravenous and intraperitoneal data sets using a two-compartment open model indicated a difference in the absorption process but not in the metabolic and blood-brain transfer processes.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2002342     DOI: 10.1111/j.1471-4159.1991.tb11425.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  46 in total

1.  Firing rate of nucleus accumbens neurons is dopamine-dependent and reflects the timing of cocaine-seeking behavior in rats on a progressive ratio schedule of reinforcement.

Authors:  S M Nicola; S A Deadwyler
Journal:  J Neurosci       Date:  2000-07-15       Impact factor: 6.167

2.  The rate of intravenous cocaine administration determines susceptibility to sensitization.

Authors:  Anne-Noel Samaha; Yilin Li; Terry E Robinson
Journal:  J Neurosci       Date:  2002-04-15       Impact factor: 6.167

3.  Transition to drug addiction: a negative reinforcement model based on an allostatic decrease in reward function.

Authors:  Serge H Ahmed; George F Koob
Journal:  Psychopharmacology (Berl)       Date:  2005-02-25       Impact factor: 4.530

4.  Ontogeny of cocaine hyperactivity and conditioned place preference in mice.

Authors:  G Laviola; G Dell'Omo; E Alleva; G Bignami
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

5.  Cocaine disinhibits dopamine neurons in the ventral tegmental area via use-dependent blockade of GABA neuron voltage-sensitive sodium channels.

Authors:  Scott C Steffensen; Seth R Taylor; Malia L Horton; Elise N Barber; Laura T Lyle; Sarah H Stobbs; David W Allison
Journal:  Eur J Neurosci       Date:  2008-11       Impact factor: 3.386

6.  Intermittent intake of rapid cocaine injections promotes the risk of relapse and increases mesocorticolimbic BDNF levels during abstinence.

Authors:  Aliou B Gueye; Florence Allain; Anne-Noël Samaha
Journal:  Neuropsychopharmacology       Date:  2018-10-26       Impact factor: 7.853

7.  The rate of intravenous cocaine administration alters c-fos mRNA expression and the temporal dynamics of dopamine, but not glutamate, overflow in the striatum.

Authors:  C R Ferrario; M Shou; A N Samaha; C J Watson; R T Kennedy; T E Robinson
Journal:  Brain Res       Date:  2008-03-07       Impact factor: 3.252

8.  Variability of drug self-administration in rats.

Authors:  Leigh V Panlilio; Jonathan L Katz; Roy W Pickens; Charles W Schindler
Journal:  Psychopharmacology (Berl)       Date:  2003-03-18       Impact factor: 4.530

9.  Varying the rate of intravenous cocaine infusion influences the temporal dynamics of both drug and dopamine concentrations in the striatum.

Authors:  Ellie-Anna Minogianis; Waqqas M Shams; Omar S Mabrouk; Jenny-Marie T Wong; Wayne G Brake; Robert T Kennedy; Patrick du Souich; Anne-Noël Samaha
Journal:  Eur J Neurosci       Date:  2018-07-24       Impact factor: 3.386

10.  Hold-down as an alternative to unit dose in cocaine self-administration experiments: Characterization using a progressive ratio schedule.

Authors:  David C S Roberts; Benjamin A Zimmer
Journal:  Psychopharmacology (Berl)       Date:  2020-05-28       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.